Loading...
No Data
SHINEWAY PHARM: TURNOVER FOR THE FIRST QUARTER OF 2022
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
SHINEWAY PHARM: Notice of Annual General Meeting
SHINEWAY PHARM: Notification Letter to Non-Registered Shareholders (Notice of Publication of Environmental, Social and Governance Report 2021 of the Company)
SHINEWAY PHARM: Notification Letter to Shareholders (Notice of Publication of Environmental, Social and Governance Report 2021 )
SHINEWAY PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021
SHINEWAY PHARM: Form of proxy for use at the annual general meeting to be held on Friday, 27 May 2022 (or at any adjournment thereof)
SHINEWAY PHARM: PROPOSALS FOR GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
SHINEWAY PHARM: Annual Report 2021
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022